Francisco Jose B. J.
- Country
- Spain
- Department
- Cardiology
Research Overview
Data & Insights
Has run more than one trial at 0 of 4 partner sites.
Specializations
Cardiovascular Medicine
Investigates mechanisms and treatments for heart failure, atrial fibrillation and atherosclerotic cardiovascular disease, including genetic forms such as dilated cardiomyopathy.
- Heart failure with preserved ejection fraction
- Atrial fibrillation management
- Primary prevention of ASCVD
- Genetic cardiomyopathy therapies
- Hypertension control strategies
Clinical work is conducted at Hospital Universitario Virgen De Las Nieves.
Oncology & Hematology
Engages in clinical research across solid tumors and hematologic malignancies such as breast cancer, prostate cancer, lung cancer, lymphoma and multiple myeloma.
- Advanced HER2‑positive breast cancer
- Castration‑resistant prostate cancer
- Non‑small cell lung cancer
- Follicular lymphoma
- Relapsed multiple myeloma
Studies encompass targeted therapies and immunotherapies.
Pulmonary & Respiratory Disorders
Addresses chronic lung diseases and acute respiratory conditions, including chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, severe asthma and progressive fibrosing interstitial lung disease.
- COPD management
- Idiopathic pulmonary fibrosis
- Severe eosinophilic asthma
- Progressive fibrosing interstitial lung disease
- Respiratory complications post‑transplant
Research integrates novel antifibrotic agents.
Autoimmune & Inflammatory Conditions
Focuses on immune‑mediated skin and systemic diseases such as atopic dermatitis, psoriasis, hidradenitis suppurativa, systemic lupus erythematosus and Sjögren’s syndrome.
- Moderate‑to‑severe atopic dermatitis
- Plaque psoriasis treatment
- Hidradenitis suppurativa therapeutics
- Systemic lupus erythematosus
- Sjögren’s syndrome clinical trials
Therapeutic strategies include biologics and small molecules.
Metabolic & Endocrine Disorders
Explores metabolic dysregulation and endocrine pathologies, including type 2 diabetes, severe hypertriglyceridemia, and broader lipoprotein disorders.
- Type 2 diabetes cardiovascular risk
- Severe hypertriglyceridemia management
- Lipoprotein(a) reduction therapies
- Obesity‑related heart failure
- Renal outcomes in diabetic kidney disease
Studies often assess cardiovascular endpoints.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.